Steven D Rubin
CIK 1381874 · Executive VP-Administration · last filed 2026-08-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OPK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
4400 BISCAYNE BLVD.
MIAMI, FL 33137
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTX | Director | 34,117 | $3.04 | $103.7K | $19.4K | 4 | 2026-08-07 |
| OPK | Executive VP-Administration | 26,663,028 | $1.61 | $43.06M | $436.2K | 40 | 2026-07-28 |
| NAGE | Director | — | $2.50 | — | $0 | 2 | 2026-06-26 |
| ELOX | Director | — | $12.57 | — | $0 | 7 | 2026-06-10 |
| RDVT | Director | 147,767 | $81.73 | $12.08M | -$389.3K | 11 | 2026-06-05 |
| COCP | Director | 2,660,242 | $0.97 | $2.58M | $0 | 7 | 2026-01-13 |
| Niagen Bioscience, Inc. (CDXC) Delisted | Director | 7,000 | $7.87 | $55.1K | $10.2K | 10 | 2024-06-24 |
| Castle Brands Inc (ROX) Delisted | Director | 22,500 | — | — | $0 | 11 | 2019-10-09 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | 1,875 | $0.07 | $122 | $0 | 4 | 2018-06-18 |
| BCDA | Interim CEO and Interim CFO | 187 | $0.93 | $173 | $0 | 1 | 2016-08-12 |
| Fluent, Inc. (IDI) Delisted | Director | 100,000 | — | — | $0 | 5 | 2016-06-03 |
| Fluent, Inc. (IDI.WS) Delisted | Director | — | — | — | $0 | 1 | 2010-01-13 |
| DREAMS INC (DRJ) Delisted | Director | — | — | — | $0 | 3 | 2009-08-05 |
| Ideation Acquisition Corp. (IDI.U) Delisted | Secretary | 157,500 | — | — | $0 | 1 | 2007-11-28 |
Recent Filings · Page 12 of 15
143 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-10-29 | — | Exer (X) | +785,383 | $196.3K | |
| 2012-10-17 | Castle Brands Inc (ROX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-04-12 | — | Exer (X) | +1,667 | $4.2K | |
| 2012-03-30 | OPK | Buy (P) | +2,000 | $9.4K | EDGAR |
| 2012-03-01 | — | Buy (P) | +100,000 | $5.0K | |
| 2012-02-17 | — | Grant (A) | — | $0 | |
| 2011-09-14 | Castle Brands Inc (ROX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-08-16 | — | Grant (A) | — | $0 | |
| 2011-03-11 | — | Grant (A) | — | $0 | |
| 2010-06-16 | — | Conv (C) | +45,420 | $25.4K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.